The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform the future organization of the Sentine...

expired opportunity(Expired)
From: Federal Government(Federal)
started - 03 Nov, 2022 (3 months ago)

Start Date

03 Nov, 2022 (3 months ago)
due - 03 Nov, 2022 (3 months ago)

Due Date

12 Dec, 2022 (1 month ago)
Bid Notification

Opportunity Type

Bid Notification
FDARFI10282022

Opportunity Identifier

FDARFI10282022
HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Customer / Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Silver Spring ,
 MD  20903  USA

Location

Silver Spring , MD 20903 USA
unlockUnlock the best of InstantMarkets.
Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.

Don't have an account yet? Create a free account now.

Contract Opportunity General Information Classification Description Attachments/Links Contact Information History Award Notices Follow The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform the future organization of the Sentinel System. Active Contract Opportunity Notice ID FDARFI10282022 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier FOOD AND DRUG ADMINISTRATION Office FDA CENTER FOR DRUG EVALUATION AND RESEARCH General Information View Changes Contract Opportunity Type: Special Notice (Updated)All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA Updated Published Date: Nov 03, 2022 08:39 am EDT Original Published Date: Nov 01, 2022 02:35 pm EDTUpdated Response Date: Dec 12, 2022 02:00 pm EST Original Response Date: Dec 12, 2022 02:00 pm ESTInactive Policy: 15 days after response date Updated Inactive Date: Original Inactive Date: Initiative: None Classification Original Set Aside: Product Service Code: B537 - SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH NAICS Code: 54171 - Research and Development in the Physical, Engineering, and Life SciencesPlace of Performance: Silver Spring , MD 20903 USA Description View Changes The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform the future organization of the Sentinel System. FDA seeks information that will assist in the exploration of alternative approaches to meet FDA’s legal requirements and fulfill its public health mission by adding value to the Sentinel System. Specifically, FDA is interested in organizational capabilities that will support the development of an efficient and economical product safety surveillance system that is not limited to the use of a common data model and a distributed data partners network and instead leverages multiple technical approaches. See Attachments for RFI.and Appendix A. Attachments/LinksDownload All Attachments/Links Attachments DocumentFile SizeAccessUpdated DateCopy of Appendix A - Supplemental Data Resource Table Final_.xlsx (opens in new window)40 KB PublicNov 03, 2022RFI number FDARFI10282022.pdf (opens in new window)203 KB PublicNov 01, 2022file uploadsContact Information Contracting Office Address 10903 New Hampshire Avenue Silver Spring , MD 20993 USA Primary Point of Contact Howard S. Yablon howard.yablon@fda.hhs.gov Secondary Point of Contact HistoryNov 03, 2022 08:39 am EDTSpecial Notice (Updated)Nov 01, 2022 02:35 pm EDTSpecial Notice (Original)

Dates

Start Date

03 Nov, 2022 (3 months ago)

Due Date

12 Dec, 2022 (1 month ago)

Location

Country : United StatesState : Maryland